Recent Blog Articles
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Dog bites: How to prevent or treat them
Will miscarriage care remain available?
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Treatments
Immunotherapy: What you need to know
Recent Blog Articles
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Dog bites: How to prevent or treat them
Will miscarriage care remain available?
